- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Fluoroquinolones Linked to Hypo-, Hyperglycemia
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
In a large cohort study, the fluoroquinolones were linked to a heightened risk of both hypo- and hyperglycemia, compared with other antibiotic classes, according to Mei-Shu Lai, MD, PhD, and colleagues at the National Taiwan University in Taipei.
The risks were low -- observed in fewer than one in 100 patients studied -- but clinicians should be cautious when treating diabetic patients with fluoroquinolones, Lai and colleagues reported online in Clinical Infectious Diseases.
"Other antibiotics should be considered if dysglycemia is a concern," Lai and colleagues argued.
Read the full story here: http://bit.ly/1cFRT4B
Source: Med Page Today
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
